Our perspectives

in one place

News

See all
Statement 17 Nov 2026

Open letter to the candidates for the post of WHO Director-General

On 17 November 2026, ahead of the WHO DG Candidates’ Forum, IFPMA Director General David Reddy shared an open letter to the candidates for the post of WHO Director General: Dr Hanan Mohammed Al-Kuwari, Dr Hanan Balkhy, Dr Hans Henri P. Kluge, Dr María P. Neira, Mr Budi Gunadi Sadikin, Dr Li Song, and Dr...

Read more
Statement 16 Nov 2026

Innovative pharmaceutical industry supports effective implementation of the Global Framework on Chemicals

On 16 November 2026, IFPMA published a statement at the start of the First International Conference on the Global Framework on Chemicals in Geneva. Recognizing that environmental sustainability and public health are intrinsically linked, the innovative pharmaceutical industry has long contributed to responsible chemicals and waste management across the value chain and supports the objectives...

Read more
Statement 12 Nov 2026

Innovative pharmaceutical industry welcomes B20 recognition of healthcare innovation as a driver of economic growth

12 November 2026, Geneva – The innovative pharmaceutical industry welcomes the Business20 (B20) Leaders’ Statement and its recognition of long-term investment in research and development (R&D) and healthcare innovation as key priorities for continued economic growth and prosperity.   The B20 USA Summit concluded in Washington with global business and policy leaders united around accelerating growth...

Read more
Statement 5 Nov 2026

Biopharmaceutical CEO Roundtable meets in New York

05 November 2026 – The Biopharmaceutical CEO Roundtable (BCR), bringing together CEOs from leading global biopharmaceutical companies, met in New York on 3–4 November to discuss the changing global policy environment and priorities for strengthening innovation, access, and the long-term competitiveness of the sector.

Read more
Statement 5 Nov 2026

WIPO’s 38th Standing Committee on Patents: Technology transfer

On 5 November 2026, IFPMA delivered a statement on technology transfer at WIPO’s 38th Standing Committee on Patents. IFPMA notes the study in document SCP/38/9 on collaboration between industry and academia. We welcome the study’s recognition that robust intellectual property frameworks, capable partners, and appropriate financing help turn research into practical applications. Furthermore, we welcome...

Read more
Statement 4 Nov 2026

WIPO’s 38th Standing Committee on Patents: Patents and health

On 4 November 2026, IFPMA delivered a statement on patents and health at WIPO’s 38th Standing Committee on Patents. A robust, stable, and predictable intellectual property system supports research and development, investment, and voluntary partnerships needed to translate scientific discoveries into innovative medicines and vaccines. As users of the patent system, including the Patent Cooperation...

Read more

Join our media mailing list

If you're a journalist, please join our mailing list to receive regular press notifications.

    Top